InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: crudeoil24 post# 45603

Tuesday, 10/25/2016 2:07:24 PM

Tuesday, October 25, 2016 2:07:24 PM

Post# of 49606
CVSI more DD/facts/numbers: 1. Pending news and pending Patent:
http://investorshub.advfn.com/uimage/uploads/2016/10/23/pdycqCVSI.png
September 19, 2016: "Our products are distributed nationally in 
health food stores, in 
health care providers’ offices and online, and we will continue 
expanding existing and new sales
channels through the education and marketing efforts in partnership with broker relationships and physician educators. 
"In the coming weeks, we will be announcing other upcoming product line extensions and new launches".
2. CVSI also hired a different IR firm, That mainly deals in NASQ stocks. Very good sign.

3. Not only CVSI has most solid and rare balance sheet w/ Assets/Liabilities Ratio of 5.5 but also no one even close to its revenues and grow rate. Market cap is still tiny compare to others w/much worse balance sheet and much lower equity

4. 500% grow rate/a year:
our top-selling brand, has more than 30 SKUs, including capsules, sprays, oils and topicals, and is sold in over 700 retail stores. This is a significant increase from the 120 locations we
 had a year ago and is a testament to the value of our brand, which continues to provide a strong platform for growth and value creation.

5.CEO: "this is a great time to be involved with CV Sciences as we move forward in this
 exciting time ahead".

6. "The Company has sufficient cash reserves and access to capital to meet its working capital requirements. Stockholders’ equity amounted to
 approximately $21.8 million as of June 30, 2016".

7. Not only The Company just Initiates Preclinical Drug Development Program to Address $5.3 Billion Market Opportunity in Cessation of Smokeless Tobacco, but also CV Sciences funds the work of the University of Kentucky's first graduate student focused entirely on hemp and cannabinoid research, who is studying various methods to increase cannabinoid production. The company plans to continue to expand research efforts with universities and Kentucky farmers through the remaining years of the pilot project.
CV Sciences just got a strong position in the industry, with continued cooperation from the Kentucky Department of Agriculture, allowed Kentucky farmers and academic institutions to be some of the first in the country to have seed in hand and in the ground.

8. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. a nice position map relating the future of marijuana legislation.

9. CVSI is led by Michael J. Mona, JR. founder of CV Sciences, Mr. Mona possesses over 30 years of senior management experience in a range of industries including real estate/construction, industrial farming, chemical processing and consumer products. Mr. Mona is a recognized industry leader in hemp farming operations and chemical extraction and has established a global supply chain of hemp-derived products.

10. Michael Joseph Mona, Jr recently revealed that they own a nice stake of 12.5%

11. CVSI is a real Company, real revenues, real suppliers, real distribution network, impressive grow rare and has a real future, while market cap still a joke relating others MJ/pot stocks.Also S.S much more atractive than most.very thin.no sign of dilution too.
most of them have zero revenues, or a negative assets/debt ratio, or going concern note and already ran hundred or thousands percents. If a mono play with 200k in assets, a double liabilities, up to 40 time deficit, zero revenues forever, and going concern ran 1500% to a market cap of 85 times it's Assets what a solid company like CVSI can do. Think about it.





My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.